Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 4921 AL 4935

Pathobiology of the autophagy-lysosomal pathway in the Huntington's disease brain

Berg MJ, Veeranna, Rosa CM, Kumar A, Mohan PS, Stavrides P, Marchionini DM, Yang DS, Nixon RA.

bioRxiv [Preprint]. 2024 May 30:2024.05.29.596470. doi: 10.1101/2024.05.29.596470.

Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification

Harding RJ, Xie Y, Caron NS, Findlay-Black H, Lyu C, Potluri N, Chandrasekaran R, Hayden MR, Leavitt BR, Langbehn DR, Southwell AL.

bioRxiv [Preprint]. 2024 Sep 27:2024.09.25.614766. doi: 10.1101/2024.09.25.614766.

Unilateral hemichorea and hemiballismus in a woman in her late 70s

Herath TM, Ahmed F, Saleh M, Nithi K.

BMJ Case Rep. 2024 Oct 24;17(10):e262688. doi: 10.1136/bcr-2024-262688.

AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia

Sikirzhytskaya A, Tyagin I, Sutton SS, Wyatt MD, Safro I, Shtutman M.

bioRxiv [Preprint]. 2024 Jun 9:2024.06.06.597745. doi: 10.1101/2024.06.06.597745.

Huntington disease - Update on ongoing therapeutic developments and a look toward the future

Sampaio C.

Parkinsonism Relat Disord. 2024 May;122:106049. doi: 10.1016/j.parkreldis.2024.106049. Epub 2024 Feb 15.

The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex(®) - A Cannabis-derived Spray

Motamedy S, Soltani B, Kameshki H, Kermani AA, Amleshi RS, Nazeri M, Shabani M.

Mini Rev Med Chem. 2024;24(15):1427-1448. doi: 10.2174/0113895575285934240123110158.

MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease

Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, Tavakol-Afshari J.

Biomed Pharmacother. 2024 Aug;177:116899. doi: 10.1016/j.biopha.2024.116899. Epub 2024 Jun 17.

The role of s-palmitoylation in neurological diseases: implication for zDHHC family

Liao D, Huang Y, Liu D, Zhang H, Shi X, Li X, Luo P.

Front Pharmacol. 2024 Jan 16;14:1342830. doi: 10.3389/fphar.2023.1342830. eCollection 2023.

Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases

Li W, Li HL, Wang JZ, Liu R, Wang X.

Cell Biosci. 2024 Feb 12;14(1):22. doi: 10.1186/s13578-023-01189-y.

Dengue and Typhoid: A Duet of Choreoathetosis

Gudibandi HV, Chinnaraj H, Vinay Vardhan M, Kumar J, Kumarasamy S.

Cureus. 2024 Sep 26;16(9):e70292. doi: 10.7759/cureus.70292. eCollection 2024 Sep.

United States' qualifying conditions compared to evidence of the 2017 National Academy of Sciences Report

Stains EL, Kennalley AL, Tian M, Boehnke KF, Kraus CK, Piper BJ.

medRxiv [Preprint]. 2024 Jul 10:2023.05.01.23289286. doi: 10.1101/2023.05.01.23289286.

Sydenham's chorea in a 16-year-old female from Bhutan: A case report

Penjor T, Dorji T, Wangchuk S.

Clin Case Rep. 2024 Jun 21;12(7):e9047. doi: 10.1002/ccr3.9047. eCollection 2024 Jul.

Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases

Rani N, Sahu M, Ambasta RK, Kumar P.

Ageing Res Rev. 2024 Feb;94:102174. doi: 10.1016/j.arr.2023.102174. Epub 2023 Dec 21.

Modifiable factors associated with Huntington's disease progression in presymptomatic participants

Gil-Salcedo A, Massart R, de Langavant LC, Bachoud-Levi AC.

Ann Clin Transl Neurol. 2024 Jul;11(7):1930-1941. doi: 10.1002/acn3.52120. Epub 2024 Jun 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias